On Invalid Date, Virios Therapeutics (NASDAQ: VIRI) reported Q2 2023 earnings per share (EPS) of -$0.08, up 81.82% year over year. Total Virios Therapeutics earnings for the quarter were -$1.44 million. In the same quarter last year, Virios Therapeutics's earnings per share (EPS) was -$0.44.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.